Legal Marijuana Helps Reduce Opioid Dangers, Studies Reveal

Another day, another round of studies suggesting that legalizing marijuana can help mitigate the harms of the opioid epidemic.

This time, one study published Oct. 25, 2018, in the journal Drug and Alcohol Dependence looked at how adult-use legalization impacted opioid prescriptions. And a separate research paper published Oct. 20, 2018, explored how medical cannabis dispensaries affect opioid overdoses.

Both studies bode well for reform advocates who’ve argued that legal marijuana can serve as a safer alternative to prescription painkillers. Here’s what you need to know about each new paper.

1. Adult-use legalization is associated with a decrease in the number of prescriptions, total doses and spending on opioids among Medicaid enrollees.

Researchers examined prescription data for Medicaid enrollees from 2010 to 2017. The team found “no evidence to support the concern that recreational marijuana legalization increased opioid prescriptions received by Medicaid enrollees.”

Rather, implementing a fully legal cannabis system in 2015 was linked to a 32 percent decrease in the total number of opioid prescriptions, a 30 percent decrease in the number of doses and a 31 percent decrease in spending on Schedule III opioids.

2. Deaths from opioid and heroin overdoses are lower in counties where medical cannabis dispensaries operate.

Looking at mortality data from 2009 to 2015, researchers found that counties with medical cannabis dispensaries experienced significantly lower rates of opioid and heroin overdoses, compared with counties without dispensaries.

Specifically, the average mortality rate for any opioid overdose increased by 0.37 per 100,000 people in counties without dispensaries from 2009 to 2015, while it increased by 0.07 per 100,000 in counties with dispensaries during the same time period. Prescription opioid mortality rates “increased by 0.05 [per 100,000]in dispensary-counties and rose by 0.2 [per 100,000]in non-dispensary counties,” according to the study.

Mortality rates associated with heroin overdoses increased by 0.61 per 100,000 people in counties with marijuana dispensaries, while increasing by nearly 1 per 100,000 in non-dispensary counties.

Both new studies come on the heels of yet another round of research on cannabis and opioids issues that came out earlier this month.

This article has been republished from Marijuana Moment under a content syndication agreement. Read the original article here.

Original Article Source: https://www.marijuana.com/news/2018/10/legal-marijuana-helps-reduce-opioid-dangers-studies-reveal/

Comments

Could CBD Lead To The Development Of Safer Antipsychotic Medications?

Antipsychotic medications are important for managing a number of different psychiatric ailments, including bipolar disorders, schizophrenia, and even dementia. These drugs can greatly improve the manageability of symptoms that often distort one’s experience of reality. They can also create major mood disruptions and lead to a number of behavioral and emotional difficulties. Antipsychotic and anti-psychosis medications can be life-changing for people with such disorders, enabling them to live more normal and manageable lives without their symptoms taking over. These drugs work by regulating neurotransmitters in the brain so that naturally occurring imbalances and dysfunctions no longer disrupt mental and emotional processes. Often, reaching this outcome is much easier said than done; it can take a lot of time to find courses and combinations of treatments that work. It’s sometimes necessary to make adjustments to find the right balance for the individual and it’s not unusual for outc...

Cannabis Watch: Canopy Growth To Book Charge Of Up To $568 Million As Marijuana Restructuring Continues

Canopy Growth Corp. said early Thursday it was halting a range of operations across three continents and expects its restructuring plans to result in a charge of up to C$800 million (567.9 million) in the fiscal fourth quarter. U.S.-traded shares US:CGC CA:WEED of the cannabis company fell 1.9% in afternoon trading. Canopy said it was selling operations in Africa, curtailing cultivation of hemp in the U.S. and Columbia, and shutting down an indoor production facility in Canada. The announcement will result in 85 job cuts, the company said. “When I arrived at Canopy Growth in January, I committed to conducting a strategic review in order to lower our cost structure and reduce our cash burn,” Canopy Chief Executive David Klein said in a statement. Read: As cannabis industry stays largely quiet on coronavirus, this CEO has been sounding the alarm Canopy’s restructuring announcement was expected by investors, Cowen analyst Vivien Azer wrote in a note to clients Thursday. Azer rate...

Can Medical Marijuana Help Aging Parents With Dementia?

For decades, marijuana, even for medical uses, was demonized or questioned. When states like Colorado legalized it for recreational use, more studies began to determine provable efficacy for its use as a medicine. The Federal government still classifies marijuana the same way it classifies heroin: harmful and with no medical benefits. Now we can see that this is wrong. When states legalized marijuana, referred to as cannabis here, they had an interest in getting data to see what good it could do. Proving efficacy could increase medical marijuana sales, benefit people who might at least find some medical use, and overall would bring tax dollars into the state coffers. Without funding studies, the Federal government has done very little to demonstrate what good cannabis can do. After all, if the presumption is that it helps nothing, there would be no motivation to determine with scientific data that it does anyone any good. But we have convincing data now about its beneficial use ...

Norma Pence

Search This Blog